30 / 36
Overview of PK and DDIs in patients treated
with abiraterone and enzalutamide
Del Re M,
et al. Cancer Treat Rev
2017;55:71–82.
|
|
30 / 36
30 / 36
Overview of PK and DDIs in patients treated
with abiraterone and enzalutamide
Del Re M,
et al. Cancer Treat Rev
2017;55:71–82.